BeiGene
ONC
390.94
-8.76
-2.19%
BeiGene
US · ONC
#538 by market cap
Listed 2016
390.94
-8.76
-2.19%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
Quant vs Street three independent views, side by side
StockVane factor grade
B
Momentum strategy signal
Hold
Analyst consensus
Buy
Mostly aligned, one view stands apart.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
✦ Quant Analyst Revision Trend how this is computed
Mixed
1 1
■ Upgrades■ Downgrades
- 1 upgrade vs 1 downgrade among tracked analyst rating changes.
- Most recent: Jefferies moved from Hold to Buy on 2026-07-12.
Analyst consensus 12 analysts
Buy
Avg price target 459.87 +17.6%
Price target rangecurrent 390.94
Low430.00
Avg459.87
High483.80
Buy 100%
Hold 0%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-11-20 | BofA Securities | -- | Buy | 483.80 |
| 2026-11-19 | J.P. Morgan | -- | Buy | 460.00 |
| 2026-11-13 | Morgan Stanley | -- | Buy | 476.00 |
| 2026-11-06 | TD Cowen | -- | Buy | 477.00 |
| 2026-11-06 | Wells Fargo | -- | Buy | 435.00 |
| 2026-11-06 | Truist Financial | -- | Buy | 448.00 |
| 2026-11-06 | Citizens JMP | -- | Buy | 463.00 |
| 2026-11-06 | Morgan Stanley | -- | Buy | 465.00 |
| 2026-11-06 | CMBI | -- | Buy | 468.62 |
| 2026-11-06 | Barclays | -- | Buy | 446.00 |
| 2026-11-05 | Guggenheim | -- | Buy | 430.00 |
| 2026-11-05 | RBC Capital | -- | Buy | 465.00 |
| 2026-10-27 | RBC Capital | -- | Buy | 459.00 |
| 2026-10-19 | Citi | -- | Buy | 466.00 |
| 2026-10-16 | Wells Fargo | -- | Buy | 400.00 |
| 2026-10-16 | Morgan Stanley | -- | Buy | 425.00 |
| 2026-10-16 | RBC Capital | -- | Buy | 459.00 |
| 2026-10-08 | Truist Financial | -- | Buy | 420.00 |
| 2026-10-08 | RBC Capital | -- | Buy | 459.00 |
| 2026-10-05 | Truist Financial | -- | Buy | -- |
| 2026-10-01 | J.P. Morgan | -- | Buy | 445.00 |
| 2026-09-10 | Barclays | -- | Buy | 415.00 |
| 2026-08-25 | RBC Capital | -- | Buy | 450.00 |
| 2026-08-09 | Wolfe Research | -- | Buy | 370.00 |
| 2026-08-07 | CMBI | -- | Buy | 442.31 |
Price target trend monthly average, last 3 years
Recent rating changes
| Date | Firm | Change | Target |
|---|---|---|---|
| 2026-07-12 | Jefferies | Hold → Buy | 380.00 |
| 2026-03-15 | Jefferies | Buy → Hold | 290.00 |
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q2 | 2026-08-05 | -- | ±6.76% | +1.40% (in line) |
| 2026/Q1 | 2026-05-06 | -- | ±5.68% | +5.32% (in line) |
| 2025/Q4 | 2026-02-26 | -- | ±8.85% | -8.48% (in line) |
| 2025/Q3 | 2025-11-06 | -- | ±8.97% | +3.41% (in line) |
| 2025/Q2 | 2025-08-06 | -- | -- | -2.84% |
| 2025/Q1 | 2025-05-07 | -- | -- | -3.93% |
| 2024/Q4 | 2025-02-27 | -- | -- | +7.48% |
| 2024/Q2 | 2024-08-07 | -- | -- | +3.16% |
| 2023/Q4 | 2024-04-29 | After close | -- | -1.65% |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
BeiGene discussion 0 comments